These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 233266)

  • 1. Preoperative cell-mediated immune status of patients with malignant glial tumors.
    Sheikh KM; Apuzzo ML; Weiss MH
    Neurol Res; 1979; 1(2):133-45. PubMed ID: 233266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological differential diagnosis of human brain tumours.
    Warecka K
    J Neurol Sci; 1975 Dec; 26(4):511-6. PubMed ID: 173807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
    Solheid C; Lauro G; Palladini G
    J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
    Wahlström T; Saksela E; Troupp H
    Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
    Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
    Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
    Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
    Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common antigen in meningioma-derived cell cultures.
    Catalano LW; Harter DH; Hsu KC
    Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary tube leukocyte adherence inhibition: an assay for cell-mediated immunity in cancer patients.
    Urist MM; Boddie AW; Holmes EC; Morton DL
    Int J Cancer; 1976 Mar; 17(3):338-41. PubMed ID: 1254356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
    Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
    J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.
    Apuzzo ML; Sheikh KM; Weiss MH; Heiden JS; Kurze T
    Acta Neurochir (Wien); 1981; 55(3-4):181-200. PubMed ID: 7015801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.